Funding for this research was provided by:
Jean Perkins Foundation
National Institute of Neurological Disorders and Stroke (5 P30 NSO69375 09)
Received: 14 July 2020
Accepted: 29 August 2020
First Online: 5 September 2020
: Drs. Massa and Longo are listed as inventors on patents relating to a compound in this report (LM11A-31) that is assigned to the University of North Carolina, University of California, San Francisco and the Dept. of Veterans Affairs. Drs. Massa and Longo are entitled to royalties distributed by UC and the VA per their standard agreements. Dr. Longo is a principal of, and has financial interest in PharmatrophiX, a company focused on the development of small molecule ligands for neurotrophin receptors that has licensed several of these patents.